Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
2.150
+0.030 (1.42%)
May 21, 2025, 3:40 PM - Market open
Innate Pharma Employees
Innate Pharma had 181 employees as of December 31, 2024. The number of employees increased by 2 or 1.12% compared to the previous year.
Employees
181
Change (1Y)
2
Growth (1Y)
1.12%
Revenue / Employee
$115,090
Profits / Employee
-$282,970
Market Cap
203.37M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
IPHA News
- 2 days ago - Innate Pharma Highlights Abstracts Selected for ASCO 2025 Annual Meeting - Business Wire
- 6 days ago - Innate Pharma Highlights ANKET® Abstracts Selected for the EHA 2025 Congress - Business Wire
- 8 days ago - Innate Pharma S.A. (IPHA) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Innate Pharma Reports First Quarter 2025 Business Update and Financial Results - Business Wire
- 15 days ago - Innate Pharma announces conference call and webcast for Q1 2025 business update - Business Wire
- 21 days ago - Innate Pharma Files Its 2024 Universal Registration Document (Document d'enregistrement universel) and 2024 Annual Report on Form 20-F - Business Wire
- 22 days ago - Innate Pharma Highlights Preclinical Anti-Tumor Efficacy Data of Its Antibody Drug Conjugate IPH4502 at the AACR 2025 Annual Meeting - Business Wire
- 27 days ago - Innate Pharma Announces €15M Investment by Sanofi - Business Wire